Other activators of PGC-1α that also increased mitochondrial biogenesis in preclinical AKI were the Sirt1 inducer SRT1720 in IRI and phosphodiesterase (PDE) inhibitors, which increase cGMP in FA-AKI [118,119]. Here, PPARGC1A is linked to acute kidney injury.